Vicissitudes of Death Anxiety During the COVID-19 Pandemic

2021 ◽  
Vol 49 (3) ◽  
pp. 384-387
Author(s):  
Norman Straker

The author, an experienced psycho-oncologist, offers clinical insights that consider the importance of death anxiety in psychodynamic psychotherapy treatments during the COVID-19 pandemic. He reviews the contributions of Ernst Becker, Wilfred Bion and Sheldon Solomon, and formulates ideas of his own based on decades of experience treating patients with cancer. This short essay focuses on how to help patients during the COVID-19 pandemic work through fear and uncertainty while developing adaptive skills.

2019 ◽  
pp. 29-34
Author(s):  
Abed Mahdavi ◽  
Hossein Jenaabadi ◽  
Seyed Rahmatollah Mosavimoghadam ◽  
Seyed Samaneh Shojaei Langari ◽  
Masoud Gholamali Lavasani ◽  
...  

Background: Considering the role of psychological components in the life of patients with cancer, the present study was conducted to investigate the relationship between mental, existential, and religious well-being and death anxiety in women with breast cancer. Methods: In this descriptive, correlational study, the statistical population included all women with breast cancer referred to Shahid Rahimi Hospital in Khorramabad in 2017. A sample of 100 patients was selected through convenience sampling and data were collected using Templer’s Death Anxiety Scale, the Warwick-Edinburgh Mental Well-being Scale, and the Spiritual Well-being Scale. For the purpose of data analysis, mean, standard deviation, Pearson’s correlation coefficient and multiple regression were applied using SPSS 22. Results: The study findings indicated a significant, negative correlation between mental well-being, existential well-being, and religious well-being and death anxiety in patients with breast cancer (α = 0.05). Conclusion: According to the results of this study, mental, existential, and religious well-being are important contributors to mental health and quality of life of patients with cancer. Therefore, enhancing these components in cancer patients can be introduced as a complementary treatment along with medical treatments in order to improve psychological problems in clinical settings.


2017 ◽  
Vol 40 (1) ◽  
pp. E1-E10 ◽  
Author(s):  
Mohammad Ali Soleimani ◽  
Rebecca H. Lehto ◽  
Reza Negarandeh ◽  
Nasim Bahrami ◽  
Yiong Huak Chan

2019 ◽  
Vol 1 (1) ◽  
pp. 24-29
Author(s):  
F Salehi ◽  
F Mohsenzade ◽  
M Arefi ◽  
S Salehi Zahabi ◽  
N Amirifard ◽  
...  

Author(s):  
Maryam Faraji Emafti ◽  
Akbar Hedayatizadeh-Omran ◽  
Asghar Noroozi ◽  
Ghasem Janbabai ◽  
Mahin Tatari ◽  
...  

2020 ◽  
Vol 48 ◽  
pp. 101803
Author(s):  
Mohammad Ali Soleimani ◽  
Nasim Bahrami ◽  
Kelly-Ann Allen ◽  
Zainab Alimoradi

Author(s):  
Seyed Reza Mirhafez ◽  
Mitra Hariri

Abstract. L-arginine is an important factor in several physiological and biochemical processes. Recently, scientists studied L-arginine effect on inflammatory mediators such as C-reactive protein (CRP), tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6). We conducted a systematic review on randomized controlled trials assessing L-arginine effect on inflammatory mediators. We searched data bases including Google scholar, ISI web of science, SCOPUS, and PubMed/Medline up to April 2019. Randomized clinical trials assessing the effect of L-arginine on inflammatory mediators in human adults were included. Our search retrieved eleven articles with 387 participants. Five articles were on patients with cancer and 6 articles were on adults without cancer. L-arginine was applied in enteral form in 5 articles and in oral form in 6 articles. Eight articles were on both genders, two articles were on women, and one article was on men. L-arginine could not reduce inflammatory mediators among patients with and without cancer except one article which indicated that taking L-arginine for 6 months decreased IL-6 among cardiopathic nondiabetic patients. Our results indicated that L-arginine might not be able to reduce selected inflammatory mediators, but for making a firm decision more studies are needed to be conducted with longer intervention duration, separately on male and female and with different doses of L-arginine.


Sign in / Sign up

Export Citation Format

Share Document